Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Natasha Kyprianou, PhD, MBBS

Cancer Center Member

James F. Hardymon Chair in Urology Research

natasha kyprianou

Research Programs:
Cancer Cell Biology and Signaling

Colleges & Departments:
College of Medicine, Department of Surgery

Faculty Rank:

Research Focus

Prostate cancer.

Contact Information

306 Combs Research Building
800 Rose Street, University of Kentucky
Lexington, KY 40536
United States



  1. Doxazosin induces apoptosis of benign and malignant prostate epithelial cells via a death receptor mediated pathway. Garrison JB and Kyprianou N. Cancer Res 66:464-472, 2006.
  2. Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity Garrison JB, Shaw Y-J, Chen C-S and Kyprianou N. Cancer Res 67(23):11344-11352, 2007.
  3. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Sakamoto S, McCann RO, Dhir R and Kyprianou N. Cancer Res 70(5):1885-1895, 2010.
  4. Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells. Zhu M and Kyprianou N. The FASEB Journal 24(3):769-777, 2010.
  5. Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. Zhu M, Horbinski C, Garzotto M, Qian D, Beer T and Kyprianou N. Cancer Res 70(20):7992-8002, 2010.